Miller, Paul D.1; Yu, Zhigang
2
Reply to letter to the editor: efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease
J Bone Miner Res. February 2023;38(2):356-356
©2023 American Society for Bone and Mineral Research (ASBMR)